Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Serial novel agents - 100004

Spotlight
Video

Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Serial novel agents

imedex has 1230 videos Subscribe Here

Loading........
Description: In this presentation from Lymphoma & Myeloma 2016, Dr. Alison Moskowitz argues in favor of the use of serial novel agents (including brentuximab and checkpoint inhibitors) for a Hodgkin lymphoma patents who relapses after autologous stem cell transplant.

Click to Earn CME Credit: http://bit.ly/2mFKBrY...

© 2016 Imedex, LLC.
Shared By : imedex
Posted on : 03/08/17
Added : 1 year ago
Category : Lymphoma